CIK 0001374690
- Non-accelerated filer
- Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203857670
- Phone
- +1 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $402,143
- in 9 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$402,143. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-03-31 | Secor Alicia Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | −53,000 | 53,000 | ||
| 2016-03-31 | Secor Alicia Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | −26,500 | 26,500 | ||
| 2015-09-17 | Secor Alicia Chief Commercial Officer | Exercise or conversion | +25,000 | $9.67 | $242K | 26,256 |
| 2015-09-17 | Secor Alicia Chief Commercial Officer | Sale | −25,000 | $41.05 | $1.0M | 1,256 |
| 2015-09-17 | Secor Alicia Chief Commercial Officer | Sale | −1,256 | $41.05 | $52K | 0 |
| 2015-09-17 | Secor Alicia Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 134,235 | ||
| 2015-02-27 | Secor Alicia Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 219,235 | ||
| 2014-06-19 | Secor Alicia Chief Commercial Officer | Purchase | +4,000 | $20.00 | $80K | 4,000 |
Page 1 of 1 · 8 trades